XBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis Suppurativa Nasdaq:XBIT

  • Alice Gottlieb

Press/Media

Period25 Jun 2019

Media coverage

1

Media coverage

  • TitleXBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis Suppurativa Nasdaq:XBIT
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    Country/TerritoryJordan
    Date25/06/19
    PersonsAlice Gottlieb